UNSPSC 51143710: Fluoxetine/olanzapine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class CN900. This VA Drug Class (CN900) classifies this compound as belonging to the group CNS MEDICATIONS, OTHER.

UNSPSC 51143710 Fluoxetine/olanzapine is a Commodity code that in practice captures pharmaceutical procurement by state and local health agencies, though the recent solicitation record shows significant misalignment between the code's nominal scope and actual buying activity. Seminole County, Florida posted an IFB (Invitation for Bid) under this code for naloxone and safe drug deactivation systems—emergency response and harm-reduction supplies unrelated to fluoxetine or olanzapine, which are psychiatric medications used to treat schizophrenia and bipolar disorder. The county's stated need is 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The procurement requires vendors to submit electronically through the county's e-Procurement Portal with all shipping and delivery costs included in bids, maintain drug-free workplace certification and E-Verify compliance, carry workers' compensation and professional liability insurance, and accept a three-month probationary termination clause.

The single recent opportunity identified under this code is Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023 (the deadline date appears to reflect a data inconsistency in the source). The contract structure includes an initial two-year term with one-year renewal option and is potentially FEMA-funded, introducing federal compliance requirements such as adherence to the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations for disadvantaged enterprises are specified. The code shows minimal recent activity in the state and local market, and the single posted opportunity diverges substantially from the code's pharmaceutical classification, suggesting either miscoding by the issuing body or limited use of this Commodity code for actual fluoxetine/olanzapine procurement at the state and local level.